NCT06171269 2026-03-04
Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life
University of Chicago
Phase NA Recruiting
Clinical Trials
17 trialsNCT04983095 2026-02-17
METRO
Umeå University
Phase NA Recruiting
NCT02454543 2026-01-12
g-RAMPP
Martini-Klinik am UKE GmbH
Phase NA Active not recruiting
NCT02069730 2026-01-08
A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes
University Health Network, Toronto
Phase NA Completed
NCT07311915 2026-01-06
Propranolol Combined With Novel Endocrine Therapy and Androgen Deprivation Therapy (ADT) for Neoadjuvant Treatment in High-Risk Prostate Cancer Patients: A Multicenter, Single-Arm Clinical Study
Zhongda Hospital
Phase NA Not yet recruiting
NCT05746806 2025-12-31
HypoFocal SRT
Insel Gruppe AG, University Hospital Bern
Phase NA Active not recruiting
NCT05628363 2025-11-05
Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer
Washington University School of Medicine
Phase NA Active not recruiting
NCT07172685 2025-09-15
Study on Triple Therapy Combined With HIFU for High-Tumor-Burden mHSPC
Qilu Hospital of Shandong University
Phase NA Recruiting
NCT05649943 2025-09-03
APPROACH
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase NA Recruiting
NCT07142967 2025-08-27
Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II)
NYU Langone Health
Phase NA Recruiting
NCT06709326 2024-11-29
APACA-Apheresis/acoustophoresis and Molecular Characterization of Prostate Cancer
Umeå University
Phase NA Recruiting
NCT01542021 2024-10-03
Androgen Deprivation Therapy Prior to Prostatectomy for Patients with Intermediate and High Risk Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01985828 2024-10-03
CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer
Wake Forest University Health Sciences
Phase NA Completed
NCT03440879 2023-03-27
Androgen Deprivation Therapy Muscle Protein Metabolism and Blood Glucose
Norwegian School of Sport Sciences
Phase NA Terminated
NCT04599699 2020-10-23
SBRT
Changhai Hospital
Phase NA Unknown
NCT03644303 2019-11-14
TRAP
Royal Marsden NHS Foundation Trust
Phase NA Unknown
NCT01811810 2019-04-23
Proton Therapy for High Risk Prostate Cancer
Abramson Cancer Center at Penn Medicine
Phase NA Withdrawn